Creo Medical Share Price | |
---|---|
Price | 36.25 |
Bid | 36.00 |
Ask | 36.50 |
Change | 0.00 (0.00%) |
Volume | 16,180 |
Open | 36.25 |
High | 36.25 |
Low | 36.25 |
Prev. Close | 36.25 |
Currency | GBX |
---|---|
Issue Country | GB |
Shares in Issue | 361.48m |
Market Capitalisation | £131.04m |
Market Size | 5,000 |
52 Week High | 49.00 |
52 Week High Date | 02-Jan-2024 |
52 Week Low | 23.25 |
52 Week Low Date | 08-Jun-2023 |
# Trades | 16 |
---|---|
Vol. Sold | 1,816 |
Sold Value | £N/A |
Vol. Bought | 14,364 |
Bought Value | £5.24k |
PE Ratio | -2.504076 |
Earnings | -14.4764 |
Dividend | 0.00 |
Yield | 0.00% |
Date | Time | Trade Prc | Volume | Buy/Sell | Bid | Ask | Value | |
---|---|---|---|---|---|---|---|---|
26-Apr-24 | 11:48:08 | 36.50 | 5,000 | Buy* | 36.00 | 36.50 | 1,825 | O Ordinary |
26-Apr-24 | 11:46:52 | 36.50 | 4,800 | Buy* | 36.00 | 36.50 | 1,752 | O Ordinary |
26-Apr-24 | 11:39:05 | 36.50 | 1,200 | Buy* | 36.00 | 36.50 | 438.00 | O Ordinary |
26-Apr-24 | 10:25:57 | 36.4735 | 27 | Buy* | 36.00 | 36.50 | 9.85 | O Ordinary |
26-Apr-24 | 10:10:22 | 36.235 | 66 | Sell* | 36.00 | 36.50 | 23.92 | O Ordinary |
26-Apr-24 | 09:58:22 | 36.2495 | 200 | Sell* | 36.00 | 36.50 | 72.50 | O Ordinary |
26-Apr-24 | 09:56:38 | 36.00 | 58 | Sell* | 36.00 | 36.50 | 20.88 | O Ordinary |
26-Apr-24 | 08:35:54 | 36.29 | 806 | Buy* | 36.00 | 36.50 | 292.50 | O Ordinary Non protected portfolio Single protected transaction |
26-Apr-24 | 08:21:07 | 36.50 | 600 | Buy* | 36.00 | 36.50 | 219.00 | O Ordinary Trade was executed as an SI |
26-Apr-24 | 08:21:07 | 36.50 | 136 | Buy* | 36.00 | 36.50 | 49.64 | O Ordinary Trade was executed as an SI |
Announced | Traded | Action | Notifier | Price | Currency | Amount | Holding |
---|---|---|---|---|---|---|---|
13-Mar-23 | 09-Mar-23 | Buy | Ivonne Cantu held the position of Independent Non-Executive Director at the time of this trade.Ivonne Cantu | 20.00 | GBX | 125,000 | 125,000 |
13-Mar-23 | 09-Mar-23 | Buy | John Bradshaw held the position of Independent Non-Executive Director at the time of this trade.John Bradshaw | 20.00 | GBX | 1,265,135 | 1,371,082 |
13-Mar-23 | 09-Mar-23 | Buy | David Gerard Woods held the position of Executive Director at the time of this trade.David Gerard Woods | 20.00 | GBX | 415,255 | 440,255 |
13-Mar-23 | 09-Mar-23 | Buy | Christopher Paul Hancock held the position of Chief Technology Officer at the time of this trade.Christopher Paul Hancock | 20.00 | GBX | 383,171 | 4,802,352 |
13-Mar-23 | 09-Mar-23 | Buy | Richard John Rees held the position of CFO at the time of this trade.Richard John Rees | 20.00 | GBX | 2,715,322 | 2,805,902 |